In a report released today, Raju Prasad from William Blair maintained a Buy rating on Beam Therapeutics (BEAM). The companys shares closed last ...
The post William Blair Sticks to Their Buy Rating for Beam Therapeutics (BEAM) appeared first on Smarter Analyst.
In a report released today, Raju ...
https://www.smarteranalyst.com/new-blurbs/william-blair-sticks-to-their-buy-rating-for-beam-therapeutics-beam/#SmarterAnalyst
Sinun täytyy kirjautua sisään ennen kuin voit kommentoida.